Ways to increase adherence to allergen immunotherapy

References

• Nurmatov U, Dhami S, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy. 2017;7:24.
   Google Scholar
• Dhami S, Zaman H, Varga E-M, et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy. 2017;72:342–365.
   PubMed Web of Science ®Google Scholar
• Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73:765–798.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J. 2014;7:6.
   PubMedGoogle Scholar
• Scott DM, Christensen T, Zhang A, Friesner DL. Does improved medication adherence reduce inpatient hospital expenditures? Int J Pharm Healthc Mark. 2017;11:248–270.
   Web of Science ®Google Scholar
• World Health Organization (WHO). Who – Adherence To Long-Term Therapies: Evidence For Action [Internet]. WHO; 2015 [cited 2018 Sep 16]. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en
   Google Scholar
• Cleemput I, Kesteloot K. Economic implications of non-compliance in health care. Lancet. 2002;359:2129–2130.
   PubMed Web of Science ®Google Scholar
• European Patients’ Forum. Adherence and Concordance [Internet]. Eur Patients Forum (EPF); 2015 [cited 2018 Aug 31]. Available from: http://www.eu-patient.eu/globalassets/policy/adherence-compliance-concordance/adherence-paper-final-rev_external.pdf
   Google Scholar
• Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006;130:S65–S72.
   PubMed Web of Science ®Google Scholar
• Lavorini F. The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy. 2013;2013:102418.
   PubMedGoogle Scholar
• Spector S. Noncompliance with asthma therapy – are there solutions? J Asthma. 2000;37:381–388.
   PubMed Web of Science ®Google Scholar
• Weinstein AG. Asthma treatment and noncompliance. Del Med J. 2000;72:209–213.
   PubMedGoogle Scholar
• Antico A. Long-term adherence to sublingual therapy: literature review and suggestions for management strategies based on patients’ needs and preferences. Clin Exp Allergy. 2014;44:1314–1326.
   PubMed Web of Science ®Google Scholar
• Bender BG, Lockey RF. Solving the problem of nonadherence to immunotherapy. Immunol Allergy Clin North Am. 2016;36:205–213.
   PubMed Web of Science ®Google Scholar
• Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377–1378.
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY Project: Evaluation of A novel SLIT formulation during a Year). Pediatr Allergy Immunol. 2007;18:58–62.
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, et al. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy. 2004;59:1205–1210.
   PubMed Web of Science ®Google Scholar
• Röder E, Berger MY, De Groot H, Gerth Van Wijk R. Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial. Clin Exp Allergy. 2008;38:1659–1667.
   PubMed Web of Science ®Google Scholar
• Cox LS, Hankin C, Lockey R. Allergy immunotherapy adherence and delivery route: location does not matter. J Allergy Clin Immunol Pract. 2014;2:156–160.
   PubMed Web of Science ®Google Scholar
• Hsu NM, Reisacher WR. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy. Int Forum Allergy Rhinol. 2012;2:280–284.
   PubMed Web of Science ®Google Scholar
• Kiel MA, Röder E, Gerth Van Wijk R, et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132:353–360.
   PubMed Web of Science ®Google Scholar
• Sieber J, De Geest S, Shah-Hosseini K, Mösges R. Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates. Curr Med Res Opin. 2011;27:855–861.
   PubMed Web of Science ®Google Scholar
• Makatsori M, Senna G, Pitsios C, et al. Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. Clin Transl Allergy. 2015;5:17.
   PubMed Web of Science ®Google Scholar
• Makatsori M, Lleonart R. Pitsios C, et al. Prospective adherence to specific immunotherapy in Europe (PASTE) – a three year survey. Allergy. 2017;S72:202–203.
   Google Scholar
• Lemberg ML, Berk T, Shah-Hosseini K, et al. Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center. Patient Prefer Adherence. 2017;11:63–70.
   PubMed Web of Science ®Google Scholar
• Musa F, Al-Ahmad M, Arifhodzic N, Al-Herz W. Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies. Hum Vaccin Immunother. 2017;13:514–517.
   PubMed Web of Science ®Google Scholar
• Scurati S, Frati F, Passalacqua G, et al. Adherence issues related to sublingual immunotherapy as perceived by allergists. Patient Prefer Adherence. 2010;4:141–145.
   PubMed Web of Science ®Google Scholar
• Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol. 1999;82:281–286.
   PubMed Web of Science ®Google Scholar
• Sánchez J. Adherence to allergen immunotherapy improves when patients choose the route of administration: subcutaneous or sublingual. Allergol Immunopathol (Madr). 2015;43:436–441.
   PubMed Web of Science ®Google Scholar
• Egert-Schmidt AM, Kolbe JM, Mussler S, Thum-Oltmer S. Patients’ compliance with different administration routes for allergen immunotherapy in Germany. Patient Prefer Adherence. 2014;8:11475–11481.
   Web of Science ®Google Scholar
• Sade K, Berkun Y, Dole Z, et al. Knowledge and expectations of patients receiving aeroallergen immunotherapy. Ann Allergy Asthma Immunol. 2003;91:444–448.
   PubMed Web of Science ®Google Scholar
• Savi E, Peveri S, Senna G, Passalacqua G. Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach. Allergy. 2013;68:1193–1195.
   PubMed Web of Science ®Google Scholar
• Calderon MA, Cox L, Casale TB, et al. The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey. All Asthma Clin Immunol. 2015;11:17.
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Rapetti A, Scurati S, et al. Importance of patient’s education in favouring compliance with sublingual immunotherapy. Allergy. 2010;65:1341–1342.
   PubMed Web of Science ®Google Scholar
• Sangasapaviliya A, Pholsuwanchai K. Attitude and knowledge of patients with asthma and allergic rhinitis who received allergen immunotherapy in Phramongkutklao Hospital. J Med Assoc Thai. 2010;93:S100–S105.
   PubMedGoogle Scholar
• Vita D, Caminiti L, Ruggeri P, Pajno GB. Sublingual immunotherapy: adherence based on timing and monitoring control visits. Allergy. 2010;65:668–669.
   PubMed Web of Science ®Google Scholar
• Lombardi C. What is the factor that improves adherence to allergen-specific immunotherapy? A secretary! Ann Allergy Asthma Immunol. 2015;114:530–531.
   PubMed Web of Science ®Google Scholar
• Alesina R, Milani M, Pecora S. A multicenter, randomized, parallel-group trial assessing compliance, tolerability, safety, and efficacy to treatment with grass allergy tablets in 261 patients with grass pollen rhinoconjunctivitis. J Allergy (Cairo). 2012;2012:673502.
   PubMedGoogle Scholar